EU Safety Gate (RAPEX) · Finland · 2025-06-13 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Sandaalien muovimateriaali sisältää liiallisen määrän dibutyyliftalaattia (DBP) ja lyijyä (mitatut arvot: 40 % ja 0,078 painoprosenttia). DBP voi vahingoittaa lasten terveyttä aiheuttamalla mahdollisia vaurioita heidän lisääntymiselimilleen. Lyijy on haitallista ihmisten terveydelle, kertyy elimistöön, voi aiheuttaa kehityksellistä neurotoksisuutta ja voi vaikuttaa myös rintaruokittuihin tai syntymättömiin lapsiin. Tuote ei täytä REACH-asetuksen vaatimuksia.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Importer
Category of measure
Destruction of the product
Date of entry into force
12/05/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Children´s sandals
Risk Description (original English): The plastic material of the sandals contains an excessive amount of dibutyl phthalate (DBP) and lead (measured values: 40% 0,078 % by weight). DBP may harm the health of children by causing possible damage to their reproductive system. Lead is harmful to human health, accumulates in the body, can cause developmental neurotoxicity and may also affect breast-fed or unborn children.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.